
Sign up to save your podcasts
Or


Dr. Norma Biln, Norma Biln, PhD, MBA, BSc, NACD.DC, one of the founders of Augurex, explains how new biomarkers, patient questionnaires, and tools like SPINEstat aim to shorten the long diagnostic delay in spondyloarthritis by improving early detection and referral accuracy, especially in primary care settings.
By The Spondylitis Association of America (SAA)4.8
3131 ratings
Dr. Norma Biln, Norma Biln, PhD, MBA, BSc, NACD.DC, one of the founders of Augurex, explains how new biomarkers, patient questionnaires, and tools like SPINEstat aim to shorten the long diagnostic delay in spondyloarthritis by improving early detection and referral accuracy, especially in primary care settings.

90,922 Listeners

38,862 Listeners

112,856 Listeners

8,654 Listeners

99,512 Listeners

9,286 Listeners

40 Listeners

188 Listeners

71 Listeners

30 Listeners

2 Listeners

150 Listeners

1,207 Listeners

3,605 Listeners